A new, onceweekly contraceptive patch ortho evra that delivers transdermally norelgestromin and ethinyl estradiol was approved by the u. Consumer information about the medication norelgestrominethinyl estradiol patch transdermal ortho evra, includes side effects, drug interactions, recommended dosages, and storage information. A transdermal contraceptive patch ortho evraevra has recently been developed and introduced into the united states contraceptive market by the r. The ortho evra contraceptive patch is a transdermal delivery system with a contact surface area of 20 cm 2. Previously published data for a transdermal system patch, n 812 and oc. The beige patch sticks to the skin and helps prevent pregnancy. Ortho evra, manufactured by ortho mcneil pharmaceuticals, is a weekly prescription method of birth control. The outside of the backing layer is heatstamped ortho evra. As the patch is applied weekly, it can offer a more convenient form of contraception that can also be used in an extended cycle manner.
How to use the birth control patch follow easy instruction. The device contains 6 mg of norelgestromin ngmn and 0. Your ortho evra patch must stick securely to your skin to work properly. The patch is applied to the skin once a week for three weeks straight. Ortho evra is the first transdermal patch approved for the prevention of pregnancy. The impact of improved compliance with a weekly contraceptive transdermal system ortho evra on contraceptive efficacy. In both trials, compliance was better with the weekly contraceptive patch than with the oc comparator. The birth control patch ortho evra is a sticker that a woman applies to her body weekly.
Evra transdermal patch summary of product characteristics. Ortho evra transdermal system orthomcneil pharmaceutical, inc. The birth control patch is a thin plastic patch 1 34 inch square placed directly on the skin of the woman. Ortho evra is the first transdermal system approved for birth control in the united states. The contraceptive patch is a small sticky patch that releases hormones into your body through your skin to prevent pregnancy. Each 20 cm 2 transdermal patch contains 6 mg norelgestromin ngmn and 600 micrograms ethinyl estradiol ee. Mathematical modeling of the release of active ingredients. Ortho evra transdermal patch weekly drug information, side. Complete the current pill cycle and apply the first. Comparative trials have shown that ortho evra has efficacy similar to the oral contraceptives mercilon not. If cycle 1 therapy starts after first day of the menstrual cycle, a nonhormonal contraceptive should be.
Ortho evra helps prevent pregnancy the same way birth control pills do. Read the patient information leaflet provided by your pharmacist before you start using this medication and each time you get a refill. Start your next cycle on your normal patch change day, the day after day 28. It is a discreet and reversible type of prescription contraception that comes in a 4x4cm thin, smooth, beige, plastic patch that sticks to a.
The ortho evra patch is the first weekly form of hormonal birth control. When used correctly, the patch is more than 99% effective at preventing pregnancy. Learn about the reported side effects, related class drugs, and how. A birth control patch is commonly known as ortho evra or evra patch. Its a transdermal patch that continuously releases two hormones an oestrogen and a progestogen that are absorbed. Data were pooled for three contraceptive studies in which women participated for up to cycles. For a list of references, send a stamped, selfaddressed envelope to. If you forget to apply your ortho evra patch at the start of your next patch cycle, you could become pregnant. Find medication information including related drug classes, side effects, patient statistics and answers to frequently asked questions.
Ortho evra norelgestromin ethinyl estradiol transdermal. In the past five years, more than four million women have used the ortho evra transdermal contraceptive patch, and there is evidence to suggest that patients are likely to be more compliant and more satisfied with transdermal contraceptive use compared with oral contraceptive oc use. The following conditions are contraindicated with this drug. Orthoevra is a poor choice for women, dr sidney wolfe of public citizen wrote the food and drug administration. Henry, pharmacy times, 241 forsgate drive, jamesburg, nj. Jul 12, 20 if you forget to remove your ortho evra patch, take it off as soon as you remember.
The initial dosage of ortho evra patches for contraception is the placement of one patch on the skin of the upper outer arm, or abdomen, or buttocks, weekly for 3 weeks 21 total days, which is to remain in place for 7 days, the fourth week is drug free. Todays video is on the patch and all the proscons i can share with you. Available in the united states since 2001, the contraceptive transdermal patch releases estrogen and progesterone directly into the skin ortho evra, ortho mcneil pharmaceutical. Ortho evra skin patches ethinyl estradiol and norelgestromin are used as a. Evra is a brand name for the contraceptive patch thats available in the uk. Check with your physician if you have any of the following. It is a hormonal method of contraception obtained by prescription. Contraceptive efficacy and cycle control with the ortho evraevra transdermal. Ortho evra norelgestromin, ethinyl estradiol transdermal.
Ortho evra fda prescribing information, side effects and. Systemic exposures as measured by area under the curve auc and steady state concentration css of ngmn and ee during use of ortho evra. The impact of improved compliance with a weekly contraceptive. Use spot on, our birth control reminder app or set a weekly alarm on your phone. It is considered a transdermal contraceptive because the hormones in the patch pass through a womans skin and. Transdermal contraceptive patch a new birth control option. Read more about the prescription drug norelgestrominethinyl estradiol patch. Our ortho evra norelgestrominethinyl estradiol side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this. The two that were comparative trials showed that the transdermal patch provides contraceptive efficacy and cycle control comparable to that of combination ocs.
Risk of venous thromboembolism vte among women aged 1544 who used the ortho evra patch compared to women who used oral contraceptives containing 3035 mcg of ethinyl estradiol ee and either levonorgestrel or norgestimate was assessed in 4 u. It is important to note that the ortho evra patch has recently been replaced with the xulane patch. On november 10, 2005 ortho mcneil, in conjunction with the fda, revised the label for ortho evra, including a new bolded warning about higher exposure to estrogen for women using the weekly patch compared to taking a daily birth control pill containing 35 g of estrogen, noting that higher levels of estrogen may put some women at increased. The patch should be changed weekly for a period of 3 weeks, and then not worn. To determine compliance with the contraceptive patch ortho evraevra overall and by age among women in north america and to compare rates of perfect use with those of an established oral contraceptive. Available in the united states since 2001, the contraceptive transdermal patch releases estrogen and progesterone directly into the skin ortho evra, orthomcneil pharmaceutical. To determine compliance with the contraceptive patch ortho evraevra overall and by age among women in north america and to compare rates of perfect use with those of an established.
Updated january 2008 ortho evra is the first transdermal skin patch approved for birth control. Assessment of compliance with a weekly contraceptive patch. Onceweekly application may improve overall compliance and provide longeracting birth control. The impact of improved compliance with a weekly contraceptive transdermal system ortho evra on contraceptive efficacy article in contraception 693. The contraceptive patch how to use it, how it works, where to get it and things you should know. Jan 27, 2020 the initial dosage of ortho evra patches for contraception is the placement of one patch on the skin of the upper outer arm, or abdomen, or buttocks, weekly for 3 weeks 21 total days, which is to remain in place for 7 days, the fourth week is drug free. The transdermal contraceptive patch is a safe and convenient birth control method that works really well if you always use it correctly. Apr 17, 2014 ortho evra is an estrogenprogestin combination hormonal contraceptive indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception.
Updated january 2008ortho evra is the first transdermal skin patch approved for birth control. Ortho evra, a new contraceptive patch researchgate. Ortho evra norelgestrominethinyl estradiol contains a combination of female hormones used as contraception to prevent pregnancy. The patch is removed and reapplied once weekly every 7 days for 3 weeks, followed by a patchfree period of 1 week before resuming the dosage cycle. Women using ortho evra, a weekly transdermal contraceptive, are exposed to 60% more estrogen than women who use birth control pills that contain 35 i. The fourth week is transdermal patchfree starting on day 22. You can choose to get a period every month, or you can skip it its totally up to you. The nurse should instruct a patient to rotate the placement site of the ortho evra transdermal patch to avoid skin irritation. The ortho evra transdermal system uses a 28day fourweek cycle.
As demonstrated in several pharmacokinetic studies, the patch delivers norelgestromin, the primary active metabolite of norgestimate 12, and. The weekly prescription patch releases norelgestromin a progestin hormone, and ethinyl estradiol an. Also in 2014 we launched estradiol transdermal system, usp, twiceweekly in 0. The birth control patch works by hormones that are absorbed from the patch into your system. Weekly birth control patch increases estrogen exposure. Xulane norelgestrominethinylestradiol dosing, indications. Complete the current pill cycle and apply the first transdermal system delivering 150 mcg of norelgestromin and 35 mcg of ethinyl estradiol per 24 hours topically to the skin on the day patient. Xulane ethinyl estradiolnorelgestromin dose, indications.
The nurse should instruct a patient to rotate the placement site of the orthoevra transdermal patch to avoid skin irritation. The initial dosage of ortho evra patches for contraception is the placement of one patch on the skin of the upper outer arm, or abdomen, or buttocks, weekly for 3 weeks 21 total days, which. As either patch type is applied weekly, it can offer a more convenient form. Ortho evra fda prescribing information, side effects and uses. Read more about the prescription drug norelgestrominethinyl estradiol patch transdermal. The weekly prescription patch releases norelgestromin a progestin hormone, and ethinyl estradiol an estrogen hormone, through the skin into the blood stream to prevent pregnancy. The patch is removed and reapplied once weekly every 7 days for 3 weeks, followed by a patch free period of 1 week before resuming the dosage cycle. Ortho evra is a combination transdermal contraceptive patch with a contact surface area of 20 cm.
Used ortho evra patches should not be flushed in the toilet. Ortho evra is an estrogenprogestin combination hormonal contraceptive indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception. Three consecutive 7day patches 21 days with 1 patchfree week per cycle. It is a discreet and reversible type of prescription contraception that comes in a 4x4cm thin, smooth, beige, plastic patch that sticks to a womans skin. Ortho evra is a thin, matrixtype transdermal contraceptive patch. Apply a new patch to the upper outer arm, abdomen, buttock or back each week for 3 weeks 21 total days. Risk of venous thromboembolism vte among women aged 1544 who used the ortho evra patch compared to women who used oral contraceptives containing 3035 mcg of ethinyl estradiol ee and. Patch drug delivery systems theoretically offer advantages over oral therapy, including enhanced adherence to treatment regimen and reduction in adverse events. You change the patch every week for 3 weeks, then have a week off without a patch. You wear the patch on certain parts of your body, and it releases hormones through your skin that prevent pregnancy.
A transdermal contraceptive patch ortho evra evra has recently been developed and introduced into the united states contraceptive market by the r. Learn about the reported side effects, related class drugs, and how these medications will affect your daily lifestyle. To throw away the ortho evra patch, fold the sticky side of the patch together, place it in a sturdy childproof container, and place the container in the trash. Each transdermal patch releases an average of 203 micrograms of ngmn and 33. Jul 12, 20 the medication from the ortho evra patch passes into breast milk and may have undesirable effects on the nursing infant. In the past five years, more than four million women have used the ortho evra transdermal contraceptive patch, and there is evidence to suggest that patients are likely to be more compliant and more. Ortho evra transdermal patch weekly drug information. First, it prevents eggs from being released from the ovaries. Read the patient information leaflet provided by your pharmacist before you start using this medication and. Ortho evra norelgestrominethinyl estradiol transdermal system. Here is the second installment of my birth control series. Remove the patch and apply a new one on the same day each week for.
Who should not take ortho evra patch, transdermal weekly. With this launch we become the first company to release a generic version of janssen pharmaceuticals inc. It is a thin, beige, plastic patch that sticks to the skin and releases ethinyl estradiol an estrogen hormone and norelgestromin a progestin hormone into the blood stream. It is a thin, beige, plastic patch that sticks to the skin and releases ethinyl estradiol an. Contraceptive efficacy and cycle control with the ortho evraevra.
650 665 1457 185 751 397 53 579 679 752 652 144 1278 272 591 951 1431 1345 1004 189 556 997 14 371 690 1335 969 1131 1478 1038 609 526 1242 629 690